Efficacy of revefenacin, a long-acting muscarinic antagonist for nebulized therapy, in patients with markers of more severe COPD: a post hoc subgroup analysis | BMC Pulmonary Medicine | Full Text
Pharmacological management of COPD .SABA = short-acting beta 2... | Download Scientific Diagram
Full article: Long-acting Muscarinic Antagonist Versus Inhaled Corticosteroid when Added to Long-acting β-agonist for COPD: A Meta-analysis
Bronchodilators: Beta 2-agonists and muscarinic antagonists | Osmosis
Understanding the role of long-acting muscarinic antagonists in asthma treatment - Annals of Allergy, Asthma & Immunology
VisualAbstract: Use of inhaled corticosteroids is not associated with improved COVID-related mortality in patients with chronic respiratory conditions | 2 Minute Medicine
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
drugs-respiratory1.ppt
Muscarinic Antagonist - an overview | ScienceDirect Topics
Preclinical Evaluation of Long-Acting Muscarinic Antagonists: Comparison of Tiotropium and Investigational Drugs | Journal of Pharmacology and Experimental Therapeutics
Inhaled long-acting muscarinic antagonists in chronic obstructive pulmonary disease | Future Medicinal Chemistry
Follow-up treatment of COPD patients. Abbreviations: laMa, long-acting... | Download Scientific Diagram
Muscarinic Antagonists - AlphaNet
Comparative Effectiveness and Safety of Different Types of Inhaled Long- Acting β2-Agonist Plus Inhaled Long-Acting Muscarinic Antagonist vs Inhaled Long-Acting β2-Agonist Plus Inhaled Corticosteroid Fixed-Dose Combinations in COPD A Propensity Score ...
Pharmacological management of chronic obstructive pulmonary disease
Long-Acting Muscarinic Receptor Antagonists (LAMA) in Clinical Development | Download Scientific Diagram
New COPD Medications - AARC
Inhaled bronchodilators for chronic bronchitis and emphysema - Document - Gale Academic OneFile
Inhaled long-acting muscarinic antagonists in asthma – A narrative review - ScienceDirect
The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review | European Respiratory Society
Placing Novel, Fixed-Dose Dual Bronchodilators within the nice Guidelines for Chronic Obstructive Pulmonary Disease -Reflections on the Past, Present and Future
Management of stable COPD. SABA, short-acting bronchodilator agonist;... | Download Scientific Diagram
New developments in inhaled therapy | Practice Nursing
![PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ba821e4f4e613ea4b521b14fa18ccc545a19bf50/5-Table2-1.png "PDF] Positioning of Long-Acting Muscarinic Antagonists in the Management of Asthma | Semantic Scholar")